BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 37361587)

  • 1. Myeloproliferative neoplasms - blurring the lines between cancer and chronic inflammatory disorder.
    Soyfer EM; Fleischman AG
    Front Oncol; 2023; 13():1208089. PubMed ID: 37361587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myeloproliferative neoplasm stem cells.
    Mead AJ; Mullally A
    Blood; 2017 Mar; 129(12):1607-1616. PubMed ID: 28159736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Host, Lifestyle and Environmental Factors in the Pathogenesis of MPN.
    Ramanathan G; Hoover BM; Fleischman AG
    Cancers (Basel); 2020 Jul; 12(8):. PubMed ID: 32722135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelets as Mediators of Thromboinflammation in Chronic Myeloproliferative Neoplasms.
    Marin Oyarzún CP; Heller PG
    Front Immunol; 2019; 10():1373. PubMed ID: 31258539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age-related macular degeneration and myeloproliferative neoplasms - A common pathway.
    Liisborg C
    Acta Ophthalmol; 2022 Oct; 100 Suppl 271(Suppl 271):3-35. PubMed ID: 36200281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Inflammatory Factors during Disease Pathogenesis and Stem Cell Transplantation in Myeloproliferative Neoplasms.
    Chatain N; Koschmieder S; Jost E
    Cancers (Basel); 2020 Aug; 12(8):. PubMed ID: 32806517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Pathogenesis of Myeloproliferative Neoplasms.
    Rolles B; Mullally A
    Curr Hematol Malig Rep; 2022 Dec; 17(6):319-329. PubMed ID: 36336766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Key Role of Inflammation in Myeloproliferative Neoplasms: Instigator of Disease Initiation, Progression. and Symptoms.
    Mendez Luque LF; Blackmon AL; Ramanathan G; Fleischman AG
    Curr Hematol Malig Rep; 2019 Jun; 14(3):145-153. PubMed ID: 31119475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammation and myeloproliferative neoplasms.
    Lussana F; Rambaldi A
    J Autoimmun; 2017 Dec; 85():58-63. PubMed ID: 28669446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting Immune Signaling Pathways in Clonal Hematopoiesis.
    Azrakhsh NA; Mensah-Glanowska P; Sand K; Kittang AO
    Curr Med Chem; 2019; 26(28):5262-5277. PubMed ID: 30907306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Always stressed but never exhausted: how stem cells in myeloid neoplasms avoid extinction in inflammatory conditions.
    Zhao HG; Deininger M
    Blood; 2023 Jun; 141(23):2797-2812. PubMed ID: 36947811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fecal Microbial Community Composition in Myeloproliferative Neoplasm Patients Is Associated with an Inflammatory State.
    Oliver A; El Alaoui K; Haunschild C; Avelar-Barragan J; Mendez Luque LF; Whiteson K; Fleischman AG
    Microbiol Spectr; 2022 Jun; 10(3):e0003222. PubMed ID: 35475626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clonal Hematopoiesis in Myeloproliferative Neoplasms Confers a Predisposition to both Thrombosis and Cancer.
    Barbui T; Gavazzi A; Sciatti E; Finazzi MC; Ghirardi A; Carioli G; Carobbio A
    Curr Hematol Malig Rep; 2023 Aug; 18(4):105-112. PubMed ID: 37221411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Current Understanding of Myeloproliferative Neoplasm-Related Gene Mutations and Cytokine -Review].
    He ZP; Wu Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Apr; 26(2):589-594. PubMed ID: 29665937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammation as a Driver of Clonal Evolution in Myeloproliferative Neoplasm.
    Fleischman AG
    Mediators Inflamm; 2015; 2015():606819. PubMed ID: 26538830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in molecular evaluation of myeloproliferative neoplasms.
    Li N; Chen M; Yin CC
    Semin Diagn Pathol; 2023 May; 40(3):187-194. PubMed ID: 37087305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clonal hematopoiesis and its evolution of myeloproliferative neoplasms].
    Zhang L; Dong H
    Zhonghua Yi Xue Za Zhi; 2023 Dec; 103(45):3608-3614. PubMed ID: 38018059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Microenvironment in Myeloproliferative Neoplasms.
    Ramanathan G; Fleischman AG
    Hematol Oncol Clin North Am; 2021 Apr; 35(2):205-216. PubMed ID: 33641864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accelerated Phase of Myeloproliferative Neoplasms.
    Shahin OA; Chifotides HT; Bose P; Masarova L; Verstovsek S
    Acta Haematol; 2021; 144(5):484-499. PubMed ID: 33882481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytological Diagnosis of Classic Myeloproliferative Neoplasms at the Age of Molecular Biology.
    Combaluzier S; Quessada J; Abbou N; Arcani R; Tichadou A; Gabert J; Costello R; Loosveld M; Venton G; Berda-Haddad Y
    Cells; 2023 Mar; 12(6):. PubMed ID: 36980287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.